Express News | CITIC Securities: The pharmaceutical Industry is expected to welcome marginal improvements.

BreakingsDec 13 14:07

Guosen's 2025 strategy for csi sws health care index: Innovation leads to industrial upgrade.

Current domestic medical demand continues to upgrade, the macro economy is expected to gradually warm up, and under geopolitical disturbances, the country is likely to increase support for self-controllable initiatives.

Zhitong FinanceDec 9 14:47

Express News | The complete list of AI application concept stocks has been revealed.

BreakingsDec 1 19:29

Research Report Gold Digging | Yongxing Securities: Aier Eye Hospital Group's performance has considerable elasticity, first giving a "shareholding" rating.

The research report from Yongxing Securities points out that aier eye hospital group (300015.SZ) has steady revenue in the Q3 report, but the gross margin is under pressure. The Q3 gross margin, net margin attributable to the parent, and net margin attributable to the parent after deducting non-recurring gains and losses are 53.9%, 24.4%, and 23.1%, respectively. According to the mid-year report, the growth of surgical volume is faster than the growth of revenue, with the unit price under pressure. The company's overseas growth is significantly faster than that in the domestic market, with revenue growth of 16.41% in Europe, mainly due to the acquisition of 100% equity of the Optimax Group in the United Kingdom through the European Clínica Baviera in the first half of the year, while the growth in the domestic industry is temporarily limited. It is believed that the future macro environment...

Gelonghui FinanceNov 28 14:25 · Ratings

Aier Eye Hospital Group (300015) 2024 third quarter report performance review: operation is stable, looking forward to consumer recovery.

Event description: The company released the third quarter report for 2024, showing stable revenue and pressure on gross margin: Revenue for the first three quarters of 2024 was approximately 16.3 billion yuan, a year-on-year increase of 1.58%; net income attributable to the parent was approximately 3.45 billion yuan, a year-on-year increase.

Yongxing SecuritiesNov 27 19:42

aier eye hospital group (300015): the global leader in ophthalmology medical services market, with continuously strengthening brand influence.

A leader in the global ophthalmology medical services market, the company continues to enhance its brand influence as a global leader in specialized ophthalmology chain medical institutions. By the end of 2023, there are a total of 881 brand hospitals, ophthalmology centers, and clinics worldwide.

Open Source SecuritiesNov 25 07:12